Unravelling mitochondrial pathways to Parkinson's disease.
about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseLC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson's diseaseMitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's diseasedATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective.Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.Nicotine from cigarette smoking and diet and Parkinson disease: a review.Screen for mitochondrial DNA copy number maintenance genes reveals essential role for ATP synthaseNeuroprotective potential of ferulic acid in the rotenone model of Parkinson's diseaseSecond Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or AstrocytesMitochondrial DNA in the regulation of innate immune responsesThe Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease.Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagyEnhancing NAD+ salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease.Autophagy in neuronal cells: general principles and physiological and pathological functions.New insights on the mitochondrial proteome plasticity in Parkinson's disease.Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer.Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease.Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease.Biological functions of selenium and its potential influence on Parkinson's disease.Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.Mitochondrial pharmacology: energy, injury and beyond.Chronic exposure to a glyphosate-containing pesticide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.Roles of Mitochondrial DNA Signaling in Immune Responses.Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivoEffect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse
P2860
Q21131066-5FA6A1B7-AFE1-4930-B99B-967C7AFD84A8Q23923990-7B7C23CA-79B4-459B-A9CC-B52CD2329592Q30831169-158ADB56-9255-4FC2-A8E9-32DA71AB0F04Q30844494-C4082085-8E22-4BAD-9D08-5344398DF593Q33625539-B6A76F22-887D-41A1-9C00-ECF66567CF0EQ33862534-2BDB6256-DFE9-42E8-B9F6-A629A6DF7C04Q34692029-7F48634D-AA89-4AE6-AEE7-F2A04E61F022Q36156137-4CF5ECE1-F9D7-4181-B4E5-D1F36C504393Q36188526-C8E6B3F6-9811-4393-B365-0CEA69F0D2BFQ36447892-DE38F093-F11C-44B7-8829-96E547D118C8Q36887309-BA52A62C-5399-4A13-8890-AA79C115D59AQ37168743-3FA821D1-C6BC-4665-87BB-317CC2B7D2F8Q37516494-AED60F15-E154-42AA-A3ED-6E7E336C3831Q37535690-C3AB5292-7F3D-4F4D-BCB5-48BAC672C168Q37644522-85CA80E6-401E-4094-B4A4-696887983F0EQ38264793-31089292-18B3-466E-B807-8FEE874FF037Q38452561-1EF7AA56-A8C4-4339-A58F-265A49C7CBEDQ38665015-6A503A1A-033E-404A-B95E-3BBE9DC447BEQ38681899-F79E0BC6-8F9C-4B4E-AFF0-9CECAF7DD7F7Q38730062-9BE214E4-2613-4D35-A741-45AB67974724Q38935901-C93335DB-30BC-4A18-902F-5E0FB1B37633Q39947651-BC6CCCC9-F4A1-4C29-9846-3DA34B9D6A16Q41228349-B53C852D-971F-4D73-A383-32917BF34526Q42374835-B1E18A89-C238-4AF6-954E-2C68372F58E6Q46251038-626F9F00-0305-4F66-BAF9-309E77DE46E7Q47099182-DA7DF293-2762-437B-90D8-4BF50C129721Q47928029-9FE38475-7166-421A-9357-B71BBBA7E55BQ49605167-B6663B8B-94E9-46E8-B914-40064EC5E6FDQ52145881-692FCECE-2DE1-4F5E-A11B-0D460400203EQ57069939-4AA8F50D-956E-487C-A8F5-17C432455CE9Q58799110-556C5817-DD72-4FA7-B502-A7CFB505A035
P2860
Unravelling mitochondrial pathways to Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Unravelling mitochondrial pathways to Parkinson's disease.
@en
type
label
Unravelling mitochondrial pathways to Parkinson's disease.
@en
prefLabel
Unravelling mitochondrial pathways to Parkinson's disease.
@en
P2093
P2860
P921
P356
P1476
Unravelling mitochondrial pathways to Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1111/BPH.12433
P407
P577
2014-04-01T00:00:00Z